Get the Newsletter Breaking
Sharp tech takes. Real opinions. Zero corporate filter.
TECH

FDA Accelerates Approval of a Rectal Cancer Drug That Could Make Treatment Easier

FDA accelerates Jemperli approval for rectal cancer as 2026 brings a wave of breakthroughs in melanoma, lung, and breast cancer research.

Oct 28, 2026 ↻ Story rotates in

Sharp tech takes. Twice a week. Free.

Join readers who get the stories the algorithm buries.

Subscribe Free →

The tech takes you won't get anywhere else.

Twice weekly. Sharp. Opinionated. Free.

Subscribe Free

Gift this article